Daniel Faga is CEO & President at ANAPTYSBIO, INC (ANAB). They have made 15 open-market trades across 3 companies since 2017, most recently 2026-03-27.
CIK 0001673528
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANAB | 510,564 | $23.8M |
| ONCE | 36,306 | $4.1M |
| MRTX | 30,638 | $1.8M |
| Total | $29.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAB | SELL | 2026-03-27 | 2026-03-27 | $61.60 | $2.2M | +20.1% | +16.7% | +4.2% |
| ANAB | SELL | 2026-01-08 | 2026-01-09 | $44.71 | $639K | +6.3% | +12.1% | +53.9% |
| ANAB | SELL | 2026-01-07 | 2026-01-08 | $45.11 | $415K | +9.2% | +16.8% | +53.3% |
| ANAB | SELL | 2026-01-05 | 2026-01-06 | $43.26 | $662K | +0.1% | +4.9% | +36.8% |
| ANAB | SELL | 2024-03-22 | 2024-03-26 | $22.75 | $6.8M | -4.5% | -12.8% | +11.1% |
| ANAB | SELL | 2024-01-08 | 2024-01-09 | $21.81 | $299K | +3.9% | +1.2% | -9.5% |
| MRTX | SELL | 2021-02-02 | 2021-02-03 | $194.38 | $521K | +2.7% | -3.1% | -21.0% |
| MRTX | SELL | 2021-01-07 | 2021-01-08 | $216.33 | $1.1M | -0.7% | -2.0% | -22.0% |
| ONCE | SELL | 2017-10-20 | 2017-10-24 | $80.96 | $607K | -3.9% | -13.2% | -32.8% |
| ONCE | SELL | 2017-09-19 | 2017-09-20 | $85.00 | $128K | +0.9% | -7.6% | -44.7% |
| ONCE | SELL | 2017-09-12 | 2017-09-14 | $82.50 | $495K | +4.0% | +4.6% | -43.9% |
| ONCE | SELL | 2017-09-07 | 2017-09-11 | $85.02 | $255K | +5.2% | +4.1% | -42.4% |
| ONCE | SELL | 2017-07-24 | 2017-07-26 | $70.00 | $210K | +6.3% | +8.6% | +15.5% |
| ONCE | SELL | 2017-06-29 | 2017-06-29 | $62.71 | $282K | -3.4% | +18.0% | +45.8% |
| ONCE | SELL | 2017-05-15 | 2017-05-17 | $56.90 | $256K | -4.9% | +8.5% | +45.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.